Open House Originale Propranolol Oral Solution
Original notice title
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-33 - Propranolol (Darreichungsform: Lösung zum Einnehmen)
Opportunity Score
Why this score?
Opportunity
62 / 100
Complexity
58 / 100
Risk factors
The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...
Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Techniker Krankenkasse
- Country
- Germany
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Dec 30, 2027
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Dec 2027
- Supply of pharmaceutical products, specifically Propranolol in oral solution form.
- Open-house contract model with uniform conditions and no individual negotiations.
Show full summary
This is an open-house style supply arrangement for Propranolol oral solution in Germany, led by Techniker Krankenkasse with hkk and HEK as participating buyers. The notice states that all suitable pharmaceutical companies may join during the contract period under uniform conditions, with no exclusivity and no individual negotiations. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the participation documents are only available electronically via the buyer portal. The extracted documents were analyzed, but the actual participation/contract documents themselves were not provided.
Risks
The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...
Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the relevant product.
- Applicant must have its seat in Germany, another EU Member State, or an EEA state.
- Applicant must hold a valid marketing authorization for the relevant medicinal product, or otherwise be entitled to place it on the market in its own name.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Originale Propranolol Oral Solution
Supply arrangement for Propranolol in oral solution form. The lot is described as a nationwide open-house contract under § 130c SGB V, with uniform terms for all eligible pharmaceutical companies. The extracted notice text indicates that participation documents are only provided to companies that market, or can credibly demonstrate they will market, the relevant medicinal product during the contract period.
Location
Duration
Category
Deadline
Award details
Die beteiligten Krankenkassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zum Wirkstoff Propranolol (Darreichungsform: Lösung zum Einnehmen) zu schließen.
Value note
Show original TED data
Original lot title
Open House Originale Rabattverträge 2025-33 - Propranolol (Darreichungsform: Lösung zum Einnehmen)
Original TED description
Die beteiligten Krankenkassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zum Wirkstoff Propranolol (Darreichungsform: Lösung zum Einnehmen) zu schließen.
Procurement Details
- Publication date
- 19 Oct 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 689646-2025
Documents (1)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
62 / 100
Complexity
58 / 100
Risk factors
The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...
Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications